NCT07208994

Brief Summary

Introduction. Chronic kidney disease (CKD) affects 10%-15% of the global population and is projected to become the fifth leading cause of years of life lost by 2040. Despite the benefits of kidney transplantation (KT), access remains inequitable. In Spain, which leads the world in KT rates per million population, disparities may persist due to structural, territorial, and professional barriers. This study aims to explore the mechanisms underlying treatment deprivation and inequity in KT access using a mixed-methods approach. Methods and analysis. A transformative mixed-methods design will be implemented in four phases: (1) systematic reviews on instruments assessing treatment deprivation and inequalities in CKD and KT; (2) a multicenter quantitative study and qualitative interviews with professionals and patients; (3) a pre-experimental evaluation of a training program on KT; and (4) triangulation and translation of findings to inform national policy. The protocol adheres to GRAMMS and PRISMA guidelines. Ethics and dissemination. Approved by the Hospital del Mar Research Institute Ethics Committee (ID: XX), the study complies with EU data protection laws. Informed consent will be obtained. Findings will be disseminated via peer-reviewed publications, conferences, social media, and patient forums to support equity-focused strategies in KT.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Jan 2026Dec 2027

First Submitted

Initial submission to the registry

June 27, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 6, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

October 6, 2025

Status Verified

June 1, 2025

Enrollment Period

12 months

First QC Date

June 27, 2025

Last Update Submit

September 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Inequities in access to kidney transplantation among individuals with chronic kidney disease

    Quantitative assessment of inequities in access to kidney transplantation using validated questionnaires developed in Phase 1, complemented by sociodemographic and clinical variables. The outcome will measure disparities according to age, sex, socioeconomic status, region, and clinical condition.

    Baseline (at study inclusion)

Secondary Outcomes (2)

  • Patient experiences related to access to kidney transplantation

    Baseline (at study inclusion)

  • Professional perspectives on inequities in access to kidney transplantation

    Within the first 12 months of the study

Other Outcomes (1)

  • Thematic categories of inequities in kidney transplantation access

    At study completion (24 months)

Interventions

No intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A transformative mixed-methods design will be implemented in four phases: (1) systematic reviews on instruments assessing treatment deprivation and inequalities in CKD and KT; (2) a multicenter quantitative study and qualitative interviews with professionals and patients; (3) a pre-experimental evaluation of a training program on KT; and (4) triangulation and translation of findings to inform national policy.

You may qualify if:

  • People with CKD

You may not qualify if:

  • Pediatrics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Escola Superior d'Infermeria Hospital del Mar

Barcelona, 08020, Spain

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Montserrat Sanclemente Dalmau, Dr

    Escola Superior d'Infermeria Hospital del Mar

    PRINCIPAL INVESTIGATOR
  • Laura Rota Musoll, Dr

    Universitat de Vic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

GUILLERMO PEDREIRA ROBLES, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 27, 2025

First Posted

October 6, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

October 6, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The following individual participant data (IPD) will be shared: de-identified sociodemographic variables (e.g., age, sex, region), clinical variables related to kidney disease stage and treatment modality, and responses to patient-reported outcome and experience measures (PROMs and PREMs) collected through standardized questionnaires. Data will be shared in aggregated and anonymized format to ensure confidentiality and will be used exclusively for research purposes in accordance with ethical approvals and participant consent.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Individual participant data (IPD) will become available after completion of the study and publication of the main results. Data will remain accessible for a period of 5 years following publication.
Access Criteria
De-identified individual participant data will be made available to qualified researchers upon reasonable request. Access will require submission of a research proposal that aligns with the study objectives, approval by the principal investigator, and a signed data access agreement to ensure compliance with ethical and legal standards.

Locations